Treatment of helminthic diseases.
D000871:Anthelmintics / Q000627:therapeutic use*; D001735:Bithionol / Q000627:therapeutic use; D002590:Cestode Infections / Q000188:drug therapy; D004049:Diethylcarbamazine / Q000627:therapeutic use; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use; D009349:Nematode Infections / Q000188:drug therapy; D009534:Niclosamide / Q000627:therapeutic use; D009560:Niridazole / Q000627:therapeutic use; D010073:Oxamniquine / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011223:Praziquantel / Q000627:therapeutic use; D011716:Pyrantel Pamoate / Q000627:therapeutic use; D011774:Pyrvinium Compounds / Q000627:therapeutic use; D013498:Suramin / Q000627:therapeutic use; D013827:Thiabendazole / Q000009:adverse effects / Q000627:therapeutic use; D014236:Trichlorfon / Q000627:therapeutic use
D000871:Anthelmintics; D010879:Piperazines; D011774:Pyrvinium Compounds; D010073:Oxamniquine; D013498:Suramin; C006589:piperazine citrate; D011223:Praziquantel; D011716:Pyrantel Pamoate; D008463:Mebendazole; D009534:Niclosamide; D001735:Bithionol; D014236:Trichlorfon; D009560:Niridazole; D013827:Thiabendazole; D004049:Diethylcarbamazine